Saliva Collection and Diagnostics Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Date : November 2024

Saliva Collection and Diagnostics Market Size Analysis and Top Companies

The global saliva collection and diagnostics market size is anticipated to reach around USD 782.75 million by 2033 increasing from USD 1,245.46 million in 2023, expanding at a CAGR of 4.76% between 2023 and 2033. The top companies in the saliva collection and diagnostics market are Thermo Fisher Scientific, Inc., Neogen Corporation, Abbott, Sarstedt AG & Co.KG, Autogen, Inc., Oasis Diagnostics, Porex, Salimetrics, LLC, Takara Bio, Inc., Arcis Bio, Orasure Technologies, and Others.

Market Report Coverage

Report Attributes Details
Market Size by 2033 USD 782.75 Million
Market Size in 2023 USD 1,245.46 Million
Market Growth Rate from 2023 to 2033 CAGR of 4.76%
Largest Market North America
Base Year 2023
Forecast Period 2023 to 2033
Segments Covered Site of Collection, Application, End-Use, and Regions
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East, & Africa

Saliva Collection and Diagnostics Lead Manufacturers

Saliva Collection And Diagnostics Lead Manufacturers

  • Thermo Fisher Scientific, Inc.
  • Neogen Corporation
  • Abbott
  • Sarstedt AG & Co.KG
  • Autogen, Inc.
  • Oasis Diagnostics
  • Porex
  • Salimetrics, LLC
  • Takara Bio, Inc.
  • Arcis Bio
  • Orasure Technologies

Latest Announcements by Market Leaders

  • In September 2024, Thermo Fisher Scientific announced the expansion of its global laboratory services with a new bioanalytical lab in GoCo Health Innovation City in Gothenburg, Sweden, that will serve pharmaceutical and biotech customers with cutting-edge laboratory services.
  • In October 2024, Neogen Corporation, an innovative leader in food safety solutions, announced that it had appointed Thierry Bernard as a director to its Board, effective November 1, 2024.

Recent Developments

  • In February 2024, Zymo Research received U.S. Food and Drug Administration (FDA) clearance for its DNA/RNA Shield SafeCollect Saliva Collection Kit for microbial nucleic acid storage and stabilization. The clearance enables the product to be used as a Class II in-vitro diagnostic (IVD) device for saliva collection and transport.
  • In January 2024, Isohelix announced the introduction of the SaliFix Saliva Swab DNA Collection Kit, which can be used at home, in the clinic, or at any remote location.
  • In October 2023, Salignostics, a startup based in Israel, created a saliva-based pregnancy test, which TIME magazine selected for the best innovation nomination in 2023.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344